CDC Panel Okays Use Of Omicron Bivalent COVID-19 Vaccines Despite Lack Of Clinical Data

 
• By Brenda Sandburg

One member says the vote was premature, but others conclude extrapolation of clinical data from another vaccine was sufficient given similar experience with flu vaccines and the potential to save thousands of lives.

Covid-19 vaccine Omicron
CDC advisory committee votes for use of omicron COVID-19 vaccine boosters authorized by FDA • Source: Shutterstock

More from Vaccines

More from Pink Sheet